BRCA2 and ovarian cancer: In this work we demonstrated that pre-cancer SOX2 overexpression in the FTE is nearly ubiquitous in HGSOCs and is also a common feature in women with BRCA1 and BRCA2 mutations prior to ovarian cancer initiation.